Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice
Inflammatory Bowel Diseases · 01.09.2025 · 31 (9) · 2535-2546
DOI: 10.1093/ibd/izaf141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 07.07.2025. Verfasst von Md Jabed Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Colitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with a complex immune-mediated pathogenesis. The efficacy of human-specific cellular immunotherapies and biological medications cannot be accurately evaluated using traditional murine IBD models. Therefore, a humanized mouse model of IBD is necessary. Regulatory T cells (Tregs) are critical for maintaining intestinal immune homeostasis and may have therapeutic potential for treating IBD.
Methods
Donor peripheral blood mononuclear cells (PBMCs) were used to reconstitute the human immune system in NOG mice and for Treg isolation. T cells were sorted and stimulated with anti-CD3 and anti-CD28 in the presence of irradiated feeder cells to prepare Treg cells. Two weeks after PBMC reconstitution in NOG mice, colitis was induced with dextran sodium sulfate (DSS). The expanded Treg cells were administered intravenously. Ozanimod was used as a positive control.
Results
After expansion, 65.4% of the live CD4+ cells were Foxp3+CD25+ Treg cells and 14.5% were non-Treg cells. The mean human leukocyte (hCD45+) engraftment rate in the humanized mice was 56.5% ± 4.5%. Autologous Treg-cell therapy significantly reduced the disease activity index by 78% on day 7. Colonic length was preserved, and colonic inflammation was reduced in mice treated with Treg cells. Immunohistology revealed reduced human T-cell infiltration in Treg-treated mice.
Conclusions
Autologous Treg therapy ameliorated the symptoms of DSS-induced colitis in a humanized mouse model. The autologous PBMC-humanized DSS-induced colitis model may serve as a robust preclinical platform for evaluating the efficacy of personalized Treg cell therapy for IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.
- Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea.
- Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, South Korea.
- Transplantation Research Institute, Medical Research Center, Seoul National University, Seoul, South Korea.
- Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, South Korea.
- Cancer Research Institute, Seoul National University, Seoul, South Korea.
ORCID-Profile: Md Jabed Khan, Young Mo Kang
Förderung
- Ministry of Science and ICT
Zitieren
APA
Khan, M. J., Lee, Y. J., Lee, S. Y., Chung, H., Nguyen-Phuong, T., Kim, Y. H., Park, C. G., & Kang, Y. M. (2025). Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice. Inflammatory Bowel Diseases, 31(9), 2535-2546. https://doi.org/10.1093/ibd/izaf141
Vancouver
Khan MJ, Lee YJ, Lee SY, Chung H, Nguyen-Phuong T, Kim YH, et al. Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice. Inflammatory Bowel Diseases. 2025;31(9):2535-2546. doi:10.1093/ibd/izaf141
BibTeX
@article{Khan2025,
author = {Khan, Md Jabed and Lee, Yoo Jin and Lee, Su Yeon and Chung, Hyeyeon and Nguyen-Phuong, Thuy and Kim, Yong-Hee and Park, Chung-Gyu and Kang, Young Mo},
title = {Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {9},
pages = {2535--2546},
doi = {10.1093/ibd/izaf141}
}
EUVIMED